Clinical Trials, Research and Development
June 17, 2022
Via: PharmaphorumThe company says it plans to use a “flexible” model, drawing on both decentralised trial (DCT) and conventional site-based models via its Health Corner and Village Medical outlets at various Walgreens locations across the US. The move follows in the […]
Clinical Trials, Research and Development
June 16, 2022
Via: PharmaphorumThe result isn’t a big surprise – Roche terminated two phase 3 trials of crenezumab in people with prodromal to mild sporadic Alzheimer’s in early 2019 after interim analyses found it would be futile to continue – but is another […]
Clinical Trials, Research and Development
June 14, 2022
Via: PharmaphorumChina’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Despite more treatment options being a positive, Ben Hargreaves finds that this has raised issues over single-region clinical […]
Clinical Trials, Research and Development
June 1, 2022
Via: FiercePharmaSanofi’s effort to switch erectile dysfunction pill Cialis to over-the-counter (OTC) availability from its original prescription status has been slowed to a grinding halt with the FDA’s decision to put a trial on hold. The FDA halted an “actual use […]
Clinical Trials, Research and Development
May 26, 2022
Via: Drugs.comMoleculin Biotech, Inc., (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced the commencement of dosing in its first-in-human Phase 1a study to evaluate the […]
Clinical Trials, Research and Development
May 23, 2022
Via: FiercePharmaSix weeks after slapping a clinical hold on a trial of Ocugen’s COVID-19 vaccine, the FDA has lifted it. That’s the good news for the Malvern, Pa. company, which has partnered with India’s Bharat Biotech on the shot known commercially […]
Clinical Trials, Research and Development
May 20, 2022
Via: FierceBiotechThe FDA has sounded a warning about Foghorn Therapeutics’ blood cancer candidate FHD-286, putting a phase 1 clinical trial on a partial hold in response to the death of a patient with potential differentiation syndrome. FHD-286 is an enzymatic inhibitor […]
Clinical Trials, Research and Development
April 20, 2022
Via: Pharma TimesCompany at the forefront of developing personalised treatments against invasive cancer has raised 15m euros to conduct clinical trials Oncomatryx has announced the beginning of a new phase in the development of its tumour microenvironment – targeted antibody drug conjugates […]
Clinical Trials, Research and Development
April 14, 2022
Via: Pharma TimesA clinical trial of Amplivant – an adjuvant technology to boost immune response to cancer therapy –has started. ISA Pharmaceuticals’ novel technology is being tested in a multicentre clinical trial which is also testing the Moditop vaccine, Modi-1. The first-in-human […]
Clinical Trials, Research and Development
April 4, 2022
Via: FierceBiotechThe list of biotechs under clinical hold keeps getting longer. Curis is the latest company to join the list, with the FDA slapping a partial hold on a phase 1/2a leukemia study while it gathers information about the death of […]
Clinical Trials, Research and Development
April 1, 2022
Via: Genetic Engineering and Biotechnology NewsResearchers are actively searching for ways to extend the survival benefit of targeted cancer therapies to prevent the possibility of highly resistant tumors. A new study led by researchers at the Duke Cancer Institute describes a potential new strategy to […]
Clinical Trials, FDA, Regulations, Research and Development
March 31, 2022
Via: Drugs.comIn a close vote, an advisory panel for the U.S. Food and Drug Administration decided not to recommend the approval of an experimental drug for the deadly neurological disease amyotrophic lateral sclerosis (ALS). The panel’s decision had been closely watched, […]